Doctor profile · Federal record
Dr. SUNG HO LEE, M.D.
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · NYACK, NY
- NPI 1841426780
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 26 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
160 N MIDLAND AVE
NYACK, NY 109601912
(845) 480-7440
fax (845) 480-7448
Credentials & registration
- NPI registered
- June 2009 — 17 yrs on file
- Profile last updated
- February 8, 2024
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- New York #270831
- Medicaid
- NY #03628140
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1841426780. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,957
Distinct HCPCS
8
Medicare allowed
$345,786
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,556 | 480 | $112 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 619 | 214 | $92 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 427 | 158 | $139 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 98 | 98 | $157 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 69 | 69 | $202 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 68 | 51 | $165 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 64 | 63 | $153 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 56 | 52 | $77 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 291. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$1,231
Transactions
48
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 12 | $189.66 | |
| ABBVIE INC. | 6 | $158.14 | |
| Eisai Inc. | 5 | $112.25 | |
| Janssen Biotech, Inc. | 4 | $99.41 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $97.27 | |
| Ipsen Biopharmaceuticals, Inc | 1 | $95.99 | |
| Merck Sharp & Dohme LLC | 3 | $60.30 | |
| ARRAY BIOPHARMA INC | 2 | $50.43 | |
| Acrotech Biopharma Inc. | 2 | $49.88 | |
| Incyte Corporation | 2 | $49.38 | |
| Celgene Corporation | 2 | $39.71 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38.52 | |
| EMD Serono, Inc. | 1 | $36.61 | |
| Sumitomo Pharma America, Inc. | 1 | $25.90 | |
| GlaxoSmithKline, LLC. | 1 | $25.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
653
Patients
107
Total drug cost
$1,414,658
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 167 | 45 | $165,162 |
| Anastrozole | Generic | 129 | 37 | $3,359 |
| Imbruvica (Ibrutinib) | Brand | 50 | 0 | $612,224 |
| Hydroxyurea | Generic | 37 | 0 | $1,140 |
| Xarelto (Rivaroxaban) | Brand | 35 | 11 | $42,809 |
| Gammaplex (Immun Glob G(Igg)/Gly/Iga 0-50) | Brand | 30 | 0 | $161,303 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 30 | 0 | $468 |
| Revlimid (Lenalidomide) | Brand | 30 | 0 | $416,970 |
| Pantoprazole Sodium | Generic | 26 | 14 | $518 |
| Letrozole | Generic | 24 | 0 | $999 |